Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Cti Biopharma Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +6 vs. Q2 2021
- Shares held
- 54.1M
- +871.2K (+1.6%) vs. Q2 2021
- Total value
- $159.6M
- +$26.5M (+19.9%) vs. Q2 2021
- New holders
- 13
- 13 more added
- Sold out
- 7
- 15 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 2 | $474.2K |
| Q1 2023 | 133 | $475.2M |
| Q4 2022 | 145 | $619.8M |
| Q3 2022 | 133 | $554.7M |
| Q2 2022 | 119 | $510.1M |
| Q1 2022 | 92 | $344.9M |
| Q4 2021 | 63 | $118.3M |
| Q3 2021 | 56 | $159.6M |
| Q2 2021 | 50 | $133.1M |
| Q1 2021 | 55 | $126.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cti Biopharma Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 33 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 46 | $0 | 0.00% | +3+7.0% | Added |
| Syverson Strege & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Bedel Financial Consulting, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 321 | $1.00K | 0.00% | −85−20.9% | Reduced |
| Wells Fargo & Company | 516 | $2.00K | 0.00% | −27−5.0% | Reduced |
| Fieldpoint Private Securities, LLC | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,230 | $10.0K | 0.00% | +3,230 | New |
| UBS Group AG | 4,278 | $13.0K | 0.00% | −2,469−36.6% | Reduced |
| JPMorgan Chase & Co | 7,283 | $21.0K | 0.00% | −2,256−23.7% | Reduced |
| Advisor Group Holdings, Inc. | 11,149 | $32.0K | 0.00% | +468+4.4% | Added |
| Victory Capital Management Inc | 12,877 | $38.0K | 0.00% | −646−4.8% | Reduced |
| KBC Group NV | 14,325 | $42.0K | 0.00% | −15,622−52.2% | Reduced |
| AQR Capital Management LLC | 15,365 | $45.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,319 | $51.0K | 0.00% | +17,319 | New |
| Cubist Systematic Strategies, LLC | 18,203 | $54.0K | 0.00% | −33,084−64.5% | Reduced |
| Wolverine Trading, LLC | 23,253 | $68.0K | 0.00% | +23,253 | New |
| Qube Research & Technologies Ltd | 24,688 | $73.0K | 0.00% | +24,688 | New |
| Bank of America Corp | 25,111 | $74.0K | 0.00% | +25,078+75,993.9% | Added |
| Barclays PLC | 26,108 | $77.0K | 0.00% | +20,503+365.8% | Added |
| Bank of New York Mellon Corp | 26,332 | $78.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 32,700 | $96.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 37,496 | $111.0K | 0.00% | +17,496+87.5% | Added |
| Group One Trading, L.P. | 38,495 | $114.0K | 0.00% | +38,495 | New |
| Capstone Investment Advisors, LLC | 50,445 | $149.0K | 0.00% | +50,445 | New |
| Knott David M | 60,000 | $177.0K | 0.07% | 00.0% | Unchanged |
| Citadel Advisors LLC | 69,673 | $205.0K | 0.00% | +69,673 | New |
| Raymond James Financial Services Advisors, Inc. | 72,871 | $215.0K | 0.00% | +72,871 | New |
| Schonfeld Strategic Advisors LLC | 76,000 | $224.0K | 0.00% | −1,000−1.3% | Reduced |
| Advisory Alpha, LLC | 103,717 | $306.0K | 0.02% | +103,717 | New |
| EPIQ Capital Group, LLC | 120,939 | $357.0K | 0.04% | +120,939 | New |
| Northern Trust Corp | 126,259 | $373.0K | 0.00% | 00.0% | Unchanged |
| Gyon Technologies Capital Management, LP | 135,003 | $398.0K | 0.11% | +135,003 | New |
| Blair William & Co | 176,198 | $520.0K | 0.00% | +100,000+131.2% | Added |
| State Street Corp | 213,314 | $629.0K | 0.00% | +47,900+29.0% | Added |
| Susquehanna International Group, LLP | 336,793 | $994.0K | 0.00% | +336,793 | New |
| Millennium Management LLC | 355,099 | $1.05M | 0.00% | +70,883+24.9% | Added |
| Kennedy Capital Management, Inc. | 504,382 | $1.49M | 0.03% | +504,382 | New |
| Morgan Stanley | 556,477 | $1.64M | 0.00% | −509,304−47.8% | Reduced |
| Geode Capital Management, LLC | 658,826 | $1.94M | 0.00% | +69,676+11.8% | Added |
| BlackRock Inc. | 895,391 | $2.64M | 0.00% | −1,660−0.2% | Reduced |
| Deutsche Bank AG | 970,435 | $2.86M | 0.00% | 00.0% | Unchanged |
| Caxton Corp | 1,000,000 | $2.95M | 2.39% | −1,314,533−56.8% | Reduced |
| Two Sigma Investments, LP | 1,069,243 | $3.15M | 0.01% | −202,576−15.9% | Reduced |
| Two Sigma Advisers, LP | 1,081,613 | $3.19M | 0.01% | −90,600−7.7% | Reduced |
| Verition Fund Management LLC | 1,136,049 | $3.35M | 0.05% | +157,370+16.1% | Added |
| Ghost Tree Capital, LLC | 1,600,000 | $4.72M | 1.56% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,789,498 | $5.28M | 0.01% | −648,935−26.6% | Reduced |
| Sofinnova Investments, Inc. | 2,074,714 | $6.12M | 0.39% | +1,903,095+1,108.9% | Added |
| Altium Capital Management LP | 3,313,000 | $9.77M | 2.61% | −365,677−9.9% | Reduced |
| Vanguard Group Inc | 3,676,004 | $10.8M | 0.00% | +9,800+0.3% | Added |
| NEA Management Company, LLC | 7,140,450 | $21.1M | 0.26% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 7,520,600 | $22.2M | 0.25% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 7,964,329 | $23.5M | 10.69% | +331,799+4.3% | Added |
| BVF Inc | 8,929,690 | $26.3M | 1.03% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −72,325−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −55,555−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −41,558−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −25,686−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |